Autonomous Therapeutics logo

Autonomous Therapeutics

Precision medicines via a new class of RNA

11 employees · est. 2017 · Rockville, United States

VS
Nobias Therapeutics logo

Nobias Therapeutics

Clinical-stage company developing novel small molecule therapeutics for rare diseases

12 employees · est. 2020 · Philadelphia, United States

Autonomous Therapeutics is the older company (2017 vs 2020).

Side-by-Side Comparison

Autonomous Therapeutics Nobias Therapeutics
Founded
2017 older 2020
Headquarters
Rockville, United States Philadelphia, United States
Employees
11 12
Industry
Biotechnology, Prop Tech Health Care, Health and Wellness
Funding Stage
Not tracked yet Series A
Total Funding
Not tracked yet $3.75M
Funding Rounds
Not tracked yet 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
RNA Therapeutics, Precision Medicine, Immunology, Infectious Diseases, Cancer Treatment, Drug Development, Therapeutics, Precision Healthcare, Biomedical Technology AI-first, Therapeutics, Clinical Trial, Anxiety Treatment, Attention Treatment, Autism Treatment, Pediatric Therapies, 22q11 Deletion Syndrome, Phase 2, Drug Development, Neurobehavioral Disorders
Website
autonomous.bio nobiastx.com
Autonomous Therapeutics logo

About Autonomous Therapeutics

Autonomous Therapeutics is a biotechnology startup founded in 2017 with a focus on developing precision and disease-activated medicines using a new class of RNA. The company's slogan, "Precision medicines via a new class of RNA," encapsulates its core mission. Through its proprietary technology, Enc...

Nobias Therapeutics logo

About Nobias Therapeutics

Nobias Therapeutics is an AI-first therapeutics company founded in 2020, with a focus on the health care sector. The company is currently engaged in a phase 2 clinical trial aimed at addressing symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndrome. Nobias has recently...

We will tell you when either one moves

BounceWatch watches Autonomous Therapeutics and Nobias Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Autonomous Therapeutic... and Nobias Therapeutics — by email.

Frequently Asked Questions

Autonomous Therapeutics — Precision medicines via a new class of RNA. Nobias Therapeutics — Clinical-stage company developing novel small molecule therapeutics for rare diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Autonomous Therapeutics has raised undisclosed funding while Nobias Therapeutics has raised $3.75M.
Autonomous Therapeutics and Nobias Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Autonomous Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Autonomous Therapeutics on 23 Nov 2024, and Nobias Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes